Glucotrack announces $11.5 million convertible notes financing
Glucotrack said it has definitive agreements for convertible notes totaling about $11.5 million, including roughly $4.5 million of new cash investment and about $4.5 million from existing notes.
Glucotrack, Inc. (NASDAQ: GCTK) said it has entered into definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million. The financing includes approximately $4.5 million of new cash investment and approximately $4.5 million of existing notes.